Oncology is entering a new phase as drugmakers and research institutions push beyond conventional cancer treatment; recent developments from Moderna, Merck, Mayo Clinic, and Bengaluru-based Sravathi AI show how cancer research is expanding
Ebola cases in the Democratic Republic of Congo (DRC) have crossed 5,000, marking a new and alarming phase in the country’s fastest-growing Ebola outbreak. Government data showed 5,021 confirmed cases as of August 16, along with 2,378 deaths.
India’s heart-lung machine market is set for a major shift as a homegrown device gains key regulatory approvals. The heart-lung machine developed by Mediyant Technologies has received USFDA 510(k) clearance and CDSCO approval.
Fake medicines remain a serious threat to India’s pharmaceutical ecosystem, even as regulators continue to tighten drug-control measures and enforcement
Indian skincare is entering a new growth phase as established consumer companies move deeper into premium and science-backed beauty
Amylyx Pharmaceuticals’ low blood sugar drug avexitide has delivered strong results in a late-stage trial. The experimental treatment cut hypoglycemic episodes by 55 percent versus placebo. The results came from a 78-patient trial involving people...
FDA approvals are driving a new phase in Indian pharma. They are helping companies expand beyond domestic markets and strengthen their presence in regulated markets
Hearzap today announced the successful completion of its acquisition of Amplifon India's hearing healthcare business. The acquisition took place after definitive agreement announced in May 2026, marking one of the most significant developments...
Tenet Diagnostics has received a major USD 30 million investment from Tata Capital Healthcare Fund III and Swiss impact investor Blue Earth Capital AG. The deal marks a fresh push into India’s growing diagnostics market. The investment will help...
CDMO platform expansion is gaining momentum at Piramal Pharma as the company takes majority control of Yapan Bio, the transaction turns Yapan Bio into a subsidiary and strengthens Piramal Pharma’s capabilities in vaccine and biologics development
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")